Hereditary angio-oedema: treatment with danazol. Report of a case

Br J Dermatol. 1979 Feb;100(2):207-12. doi: 10.1111/j.1365-2133.1979.tb05562.x.

Abstract

An 8-year-old boy with hereditary angio-oedema was treated with danazol under close endocrinological supervision. The boy's C1 esterase inhibitor (C1inh) and C4 levels increased rapidly to near normal values under a daily dose of 400 mg and were maintained at about 50% of the normal by maintenance doses of 200 mg danazol every other day. Throughout the entire treatment period (11 months) the boy has been maintained free from attacks of angio-oedema. No hormonal imbalance was detected in the follow-up period. Our results indicate that danazol should be suitable for the treatment of HAE not only in adults but also in prepubescent children.

Publication types

  • Case Reports

MeSH terms

  • Angioedema / drug therapy
  • Angioedema / genetics*
  • Angioedema / immunology
  • Child
  • Complement C1 Inactivator Proteins / blood
  • Complement C4 / analysis
  • Danazol / administration & dosage
  • Danazol / therapeutic use*
  • Drug Administration Schedule
  • Humans
  • Male
  • Pedigree
  • Pregnadienes / therapeutic use*

Substances

  • Complement C1 Inactivator Proteins
  • Complement C4
  • Pregnadienes
  • Danazol